Position in ADCT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,112
-$1,508 QoQ
Shares Held
5,713
+181.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 113 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026State of Wyoming holds $8,248,921 across 35 Drug Manufacturers - Specialty & Generic names. ADCT ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
13,691 | $717,408 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
10,326 | $660,347 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
13,100 | $619,237 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
58,264 | $582,640 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
28,930 | $500,778 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
17,609 | $433,357 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
101,781 | $428,498 | |
| 8 | VTRS |
Viatris Inc
|
26,837 | $426,171 |
All Filings in ADCT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,112 | 5,713 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,620 | 2,032 | Shares | Sole | 2026-05-13 | |
| 2024-12-31 | $16,451 | 8,267 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $19,658 | 6,221 | Shares | Sole | 2024-08-14 | |
| 2022-03-31 | $42,336 | 2,882 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,865 | 1,825 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $42,070 | 1,549 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $57,368 | 2,356 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $21,358 | 875 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||